| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/14/2010 | WO2009131681A3 Hcv e2 construct compositions and methods |
| 01/14/2010 | WO2009125986A3 Lyophilized dna formulations for enhanced expression of plasmid dna |
| 01/14/2010 | WO2009124312A3 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same |
| 01/14/2010 | WO2009117373A3 Treatment and prevention of gardnerella vaginalis infections |
| 01/14/2010 | WO2009108235A3 Compositions and methods for modulating immune responses to nucleic acids |
| 01/14/2010 | WO2009105759A9 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |
| 01/14/2010 | WO2009082744A3 Prognosis and interference-mediated treatment of breast cancer |
| 01/14/2010 | WO2008106662A3 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | WO2008086094A3 Microarray-based lineage analysis as a diagnostic for current and emerging strains of influenza b |
| 01/14/2010 | WO2005097421A9 Methods for identifying risk of osteoarthritis and treatments thereof |
| 01/14/2010 | WO2005072050A9 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 01/14/2010 | WO2003083054A9 Amylases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | US20100011463 Compositions and Methods Using RNA Interference for Control of Nematodes |
| 01/14/2010 | US20100011462 Flavin monooxygenases and transcription factors involved in glucosinolate biosynthesis |
| 01/14/2010 | US20100011460 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100010209 Method and apparatus for combinatorial chemistry |
| 01/14/2010 | US20100010208 Purification of a triple helix formation with an immobilized oligonucleotide |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010206 siRNA Targeting Hypoxia-Inducible Factor 1 |
| 01/14/2010 | US20100010196 Compositions and methods for non-targeted activation of endogenous genes |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100010073 Microrna (mirna) for the diagnosis and treatment of heart diseases |
| 01/14/2010 | US20100010072 Microrna biomarkers for human breast and lung cancer |
| 01/14/2010 | US20100010071 Compositions and use of EPAS1 inhibitors |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009905 Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer |
| 01/14/2010 | US20100009858 Embryonic stem cell markers for cancer diagnosis and prognosis |
| 01/14/2010 | US20100009856 Randomized dna libraries and double-stranded rna libraries, use and method of production thereof |
| 01/14/2010 | US20100009451 Compositions and methods for specifically silencing a target nucleic acid |
| 01/14/2010 | US20100009446 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009435 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
| 01/14/2010 | US20100009415 introducing a DNA encoding an enzyme which hydrolyzes an amido bond of L-amino acid amide, especially L-2-alkylcysteine amide; |
| 01/14/2010 | US20100009412 Novel Oligonucleotide Primers and Methods for DNA Replication |
| 01/14/2010 | US20100009410 Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing |
| 01/14/2010 | US20100009409 Molecular variant fibrinogen fusion proteins |
| 01/14/2010 | US20100009384 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders |
| 01/14/2010 | US20100009368 Methods and compositions for the assessment of cardiovascular function and disorders |
| 01/14/2010 | US20100009366 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 01/14/2010 | US20100009361 Compositions and methods for detecting noonan syndrome |
| 01/14/2010 | US20100009354 Method for determining base sequence of dna |
| 01/14/2010 | US20100009353 Dye Compounds and the Use of their Labelled Conjugates |
| 01/14/2010 | US20100009346 Lafora's disease gene |
| 01/14/2010 | US20100009341 Methods and means for assessing hiv gag/protease inhibitor therapy |
| 01/14/2010 | US20100008944 Herpes simplex virus mutant and uses therefore |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008921 Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative Diseases |
| 01/14/2010 | US20100008908 Treatment of Heart Failure |
| 01/14/2010 | US20100008906 Cripto binding molecules |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008903 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 01/14/2010 | US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins |
| 01/14/2010 | US20100008871 New Biochemical Route to Astaxanthin |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/13/2010 | EP2143726A1 Nucleic acid comprising zwitterionic nucleotides |
| 01/13/2010 | EP2142672A2 Compositions and methods for gene silencing |
| 01/13/2010 | CN201381292Y RNA extraction kit for paraffin-embedded tissue |
| 01/12/2010 | US7645919 Controlling gene expression in plants |
| 01/12/2010 | US7645872 Compounds and methods for labeling oligonucleotides |
| 01/12/2010 | US7645871 Tumor inhibition by modulating sprouty expression of activity |
| 01/12/2010 | US7645870 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 01/12/2010 | US7645869 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 01/12/2010 | US7645868 Family of minimally cross-hybridizing oligonucleotide sequences for use in nucleic acid detection assays; gene expression analysis; genomics |
| 01/12/2010 | US7645867 DNA molecules encoding ligand gated ion channels from Dermacentor variabilis |
| 01/12/2010 | US7645866 Methods of producing and sequencing modified polynucleotides |
| 01/12/2010 | US7645865 System for monitoring the location of transgenes |
| 01/12/2010 | US7645744 Compositions and methods for siRNA inhibition of HIF-1 alpha |
| 01/12/2010 | US7645743 Administering immunity linkers with more than one binding site, wherein second site binds to target and individual has pre-existing cellular or humoral immune response to first site; high speed response to public health needs such as pandemic infections; biological warfare; vaccines |
| 01/12/2010 | US7645605 Heat-resistant nitrile hydratase |
| 01/12/2010 | US7645604 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 01/12/2010 | US7645603 Cells having cardiac glycoside resistance |
| 01/12/2010 | US7645602 Host cell comprising a recombinant nucleic acid coding for a vitamin K epoxide reductase (VKOR) |
| 01/12/2010 | US7645600 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 01/12/2010 | US7645599 Specific, asymmetric reduction of 3-quinuclidinone using tropinone reductase-I in the presence of a reduced coenzyme to produce (R)-3-quinuclidinol; high optical purity |
| 01/12/2010 | US7645598 Polyunsaturated fatty acids (PUFA); from Shewanella japonica and Shewanella olleyana; beta -ketoacyl-ACP reductase (KR) activity; recombinant microbial, plant cells |
| 01/12/2010 | US7645597 PUFA polyketide synthase systems and uses thereof |
| 01/12/2010 | US7645596 Polymerase chain reactions; exonucleases; microfluidics |
| 01/12/2010 | US7645580 Forensic identification |
| 01/12/2010 | US7645576 Method for the detection of chromosomal aneuploidies |
| 01/12/2010 | US7645575 for determining likelihood of human patient to reject cardiac transplant |
| 01/12/2010 | US7645574 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces |
| 01/12/2010 | US7645572 Shows a high accuracy and a high estimation ratio; analyzing 2 or more polymorphisms among 6 gene polymorphisms proved as relating to restenosis after balloon expansion or 5 gene polymorphisms |
| 01/12/2010 | US7645571 Target-specific hybrid capture (TSHC) for enhanced detection of homologous nucleotide sequences; classifying microorganisms; diagnosing infection, genetic abnormality and cell proliferative disorders |
| 01/12/2010 | US7645455 Chimeric lyssavirus nucleic acids and polypeptides |
| 01/12/2010 | US7645448 Prevention, therapy of pathogen infections; anchoring on surface of target cells; viricides; gene therapy; neuraminidase activity; antiallergens; antiinflammatory agents |
| 01/12/2010 | CA2402339C Viral antigen and vaccine against isav (infectious salmon anaemia virus) |
| 01/12/2010 | CA2259523C Electrochemical solid phase synthesis of polymers |
| 01/12/2010 | CA2172142C Primers and probes for the amplification and detection of cmv nucleic acid |
| 01/07/2010 | WO2010003008A1 Tomatoes that soften more slowly post-harvest due to non-transgenic alterations in an expansin gene |
| 01/07/2010 | WO2010002851A1 Silencing and rig-1 activation by dual function oligonucleotides |
| 01/07/2010 | WO2010002537A1 Cattle vaccines |
| 01/07/2010 | WO2010002468A1 A functional complementation assay for defined gpcr oligomers |
| 01/07/2010 | WO2010001074A2 Novel detection probe |
| 01/07/2010 | WO2009140383A3 Aptamers that bind to p-selectin and their use as coagulation, thrombotic, inflammatory, and metastatic disease therapeutics |